- Home
- AQST vs HIVE Comparison
AQST vs HIVE Comparison
Compare AQST & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- HIVE
- Stock Information
- Founded
- AQST 2004
- HIVE 1987
- Country
- AQST United States
- HIVE Canada
- Employees
- AQST N/A
- HIVE N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- HIVE
- Sector
- AQST Health Care
- HIVE
- Exchange
- AQST Nasdaq
- HIVE Nasdaq
- Market Cap
- AQST 274.4M
- HIVE 276.6M
- IPO Year
- AQST 2018
- HIVE N/A
- Fundamental
- Price
- AQST $3.02
- HIVE $1.50
- Analyst Decision
- AQST Strong Buy
- HIVE Strong Buy
- Analyst Count
- AQST 7
- HIVE 7
- Target Price
- AQST $10.57
- HIVE $7.64
- AVG Volume (30 Days)
- AQST 1.3M
- HIVE 8.7M
- Earning Date
- AQST 03-05-2025
- HIVE 02-11-2025
- Dividend Yield
- AQST N/A
- HIVE N/A
- EPS Growth
- AQST N/A
- HIVE N/A
- EPS
- AQST N/A
- HIVE N/A
- Revenue
- AQST $57,561,000.00
- HIVE $120,999,000.00
- Revenue This Year
- AQST N/A
- HIVE $2.40
- Revenue Next Year
- AQST $35.72
- HIVE $179.59
- P/E Ratio
- AQST N/A
- HIVE N/A
- Revenue Growth
- AQST 13.79
- HIVE 26.29
- 52 Week Low
- AQST $2.24
- HIVE $1.48
- 52 Week High
- AQST $5.80
- HIVE $5.54
- Technical
- Relative Strength Index (RSI)
- AQST 50.92
- HIVE 28.71
- Support Level
- AQST $3.05
- HIVE $1.62
- Resistance Level
- AQST $3.24
- HIVE $1.83
- Average True Range (ATR)
- AQST 0.20
- HIVE 0.10
- MACD
- AQST 0.04
- HIVE 0.02
- Stochastic Oscillator
- AQST 57.47
- HIVE 5.71
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.